Interestingly, OSA patients frequently present an increase in TGF-β levels [15,23,24] suggesting that the pathways dependent on its activation could play a role in the high rates of atherosclerotic patients among OSA subjects. This evidence concerns the gene TGFB1 and obstructive sleep apnea syndrome.